WEBSITE BSE:507753 NSE: TGVSL Inc. Year: 1981 Industry: Chemicals My Bucket: Add Stock
Last updated: 11:27
No Notes Added Yet
TGV SRAAC Ltd manufactures and sells chlor-alkali products, chloromethane, castor derivatives, and fatty acids in India. The employer operates via Chemicals, and Oils & Fats segments. Its castor derivatives include hydrogenated castor oil, 12-hydroxy stearic acid, ricinoleic acid, refined castor oil, methyl 12 hydroxy stearate, sodium sulphate, and castor (ricinoleic) methyl ester. The corporation additionally offers chlor-alkali merchandise, such as caustic soda and potash, liquid chlorine, hydrochloric acid, hydrogen gas, sodium hypochlorite,...Read More
TGV SRAAC Ltd manufactures and sells chlor-alkali products, chloromethane, castor derivatives, and fatty acids in India. The employer operates via Chemicals, and Oils & Fats segments. Its castor derivatives include hydrogenated castor oil, 12-hydroxy stearic acid, ricinoleic acid, refined castor oil, methyl 12 hydroxy stearate, sodium sulphate, and castor (ricinoleic) methyl ester. The corporation additionally offers chlor-alkali merchandise, such as caustic soda and potash, liquid chlorine, hydrochloric acid, hydrogen gas, sodium hypochlorite, barium sulphate, potassium carbonate, and sodium hypo; and stearic acid, soaps noodles, refined glycerine, and hydrogenated palm stearin. In addition, it provides chloromethane merchandise comprising methyl chloride, methylene chloride, chloroform, and carbon tetra chloride, in addition to rest room soaps. TGV SRAAC Ltd also exports its merchandise to Canada, China, Dubai, France, Georgia, Germany, Greece, Iran, Italy, Japan, Jordan, Kenya, Korea, Kuwait, Malaysia, the Netherlands, Poland, Russia, Singapore, Spain, Sri Lanka, Saudi Arabia, Thailand, the US, the UK, and different nations. It additionally generates power through thermal and windmills. The employer became formerly known as Sree Rayalaseema Alkalies and Allied Chemicals Ltd. And modified its call to TGV SRAAC Ltd in October 2017. TGV SRAAC Ltd changed into integrated in 1981 and is primarily based in Kurnool, India. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1078 Cr.
Stock P/E 11.7
P/B 0.8
Current Price ₹100.7
Book Value ₹ 119.8
Face Value 10
52W High ₹142.3
Dividend Yield 0.99%
52W Low ₹ 78.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 360 | 402 | 368 | 379 | 428 | 455 | 487 | 491 | 500 | 448 |
| Other Income | 3 | 4 | 7 | 3 | 2 | 4 | 5 | 5 | 3 | 6 |
| Total Income | 363 | 406 | 375 | 382 | 430 | 459 | 492 | 496 | 503 | 454 |
| Total Expenditure | 333 | 358 | 354 | 337 | 360 | 399 | 428 | 396 | 407 | 371 |
| Operating Profit | 30 | 48 | 20 | 45 | 71 | 60 | 64 | 99 | 96 | 84 |
| Interest | 5 | 6 | 7 | 6 | 5 | 6 | 9 | 7 | 6 | 4 |
| Depreciation | 21 | 21 | 22 | 21 | 21 | 21 | 25 | 40 | 40 | 42 |
| Exceptional Income / Expenses | 21 | 0 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 25 | 21 | 10 | 19 | 45 | 32 | 30 | 52 | 50 | 38 |
| Provision for Tax | 7 | 6 | 3 | 5 | 12 | 8 | 8 | 14 | 13 | 10 |
| Profit After Tax | 19 | 15 | 7 | 14 | 33 | 24 | 22 | 39 | 37 | 28 |
| Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit After Adjustments | 19 | 15 | 7 | 14 | 33 | 24 | 22 | 39 | 37 | 28 |
| Adjusted Earnings Per Share | 1.7 | 1.4 | 0.7 | 1.3 | 3.1 | 2.2 | 2 | 3.6 | 3.5 | 2.6 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 777 | 816 | 931 | 1189 | 1205 | 1040 | 1009 | 1525 | 2326 | 1546 | 1749 | 1926 |
| Other Income | 6 | 5 | 9 | 7 | 5 | 8 | 10 | 7 | 7 | 18 | 14 | 19 |
| Total Income | 782 | 822 | 940 | 1195 | 1210 | 1048 | 1019 | 1532 | 2332 | 1564 | 1763 | 1945 |
| Total Expenditure | 669 | 704 | 794 | 987 | 964 | 883 | 859 | 1219 | 1786 | 1412 | 1520 | 1602 |
| Operating Profit | 114 | 118 | 146 | 208 | 246 | 166 | 160 | 313 | 546 | 153 | 244 | 343 |
| Interest | 40 | 44 | 60 | 58 | 71 | 44 | 48 | 35 | 30 | 25 | 30 | 26 |
| Depreciation | 36 | 35 | 47 | 77 | 58 | 56 | 63 | 69 | 74 | 83 | 88 | 147 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -12 | 0 | 0 | 0 | 0 | 40 | 0 | 0 |
| Profit Before Tax | 37 | 39 | 40 | 73 | 105 | 65 | 49 | 209 | 442 | 84 | 126 | 170 |
| Provision for Tax | 9 | 8 | 18 | 23 | 27 | 17 | 19 | 75 | 80 | 23 | 33 | 45 |
| Profit After Tax | 28 | 30 | 22 | 50 | 78 | 48 | 30 | 135 | 362 | 61 | 92 | 126 |
| Adjustments | -6 | -6 | -5 | -21 | -10 | -1 | -1 | -0 | -0 | -0 | -0 | 0 |
| Profit After Adjustments | 22 | 24 | 17 | 30 | 68 | 47 | 29 | 134 | 362 | 61 | 92 | 126 |
| Adjusted Earnings Per Share | 3.6 | 3.6 | 2.5 | 5.5 | 8.1 | 4.7 | 2.8 | 12.6 | 33.8 | 5.7 | 8.6 | 11.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 13% | 5% | 11% | 8% |
| Operating Profit CAGR | 59% | -8% | 8% | 8% |
| PAT CAGR | 51% | -12% | 14% | 13% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 2% | -4% | 25% | 18% |
| ROE Average | 8% | 18% | 16% | 14% |
| ROCE Average | 11% | 19% | 18% | 16% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 297 | 338 | 347 | 382 | 479 | 537 | 610 | 744 | 1047 | 1096 | 1178 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 98 | 160 | 157 | 133 | 122 | 176 | 253 | 181 | 71 | 79 | 66 |
| Other Non-Current Liabilities | 69 | 70 | 80 | 124 | 154 | 181 | 167 | 212 | 185 | 179 | 207 |
| Total Current Liabilities | 354 | 404 | 497 | 457 | 347 | 385 | 428 | 495 | 485 | 454 | 541 |
| Total Liabilities | 818 | 972 | 1081 | 1096 | 1103 | 1279 | 1459 | 1632 | 1786 | 1808 | 1992 |
| Fixed Assets | 444 | 660 | 698 | 669 | 636 | 808 | 774 | 902 | 1041 | 1048 | 1269 |
| Other Non-Current Assets | 163 | 43 | 66 | 89 | 118 | 80 | 245 | 170 | 92 | 260 | 109 |
| Total Current Assets | 210 | 268 | 316 | 339 | 349 | 391 | 440 | 559 | 653 | 499 | 614 |
| Total Assets | 818 | 972 | 1081 | 1096 | 1103 | 1279 | 1459 | 1632 | 1786 | 1808 | 1992 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 22 | 33 | 3 | 3 | 5 | 7 | 7 | 32 | 15 | 20 | 11 |
| Cash Flow from Operating Activities | 65 | 50 | 142 | 153 | 202 | 122 | 132 | 168 | 429 | 164 | 195 |
| Cash Flow from Investing Activities | -52 | -132 | -109 | -75 | -55 | -188 | -163 | -147 | -169 | -223 | -170 |
| Cash Flow from Financing Activities | -2 | 91 | -33 | -76 | -145 | 65 | 58 | -38 | -255 | 49 | -3 |
| Net Cash Inflow / Outflow | 11 | 9 | -0 | 2 | 2 | -0 | 26 | -18 | 5 | -9 | 22 |
| Closing Cash & Cash Equivalent | 33 | 42 | 3 | 5 | 7 | 7 | 32 | 15 | 20 | 11 | 33 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.55 | 3.64 | 2.51 | 5.48 | 8.1 | 4.72 | 2.78 | 12.56 | 33.81 | 5.7 | 8.62 |
| CEPS(Rs) | 8.18 | 7.93 | 7.86 | 13.82 | 14.11 | 10.25 | 8.67 | 18.97 | 40.68 | 13.49 | 16.85 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Book NAV/Share(Rs) | 35.33 | 37.36 | 39.52 | 41.64 | 48.56 | 52.25 | 56.98 | 69.42 | 97.73 | 102.32 | 110.02 |
| Core EBITDA Margin(%) | 12.34 | 12.22 | 13.34 | 16.57 | 17.15 | 15.13 | 14.86 | 20.07 | 23.2 | 8.69 | 13.12 |
| EBIT Margin(%) | 8.83 | 8.96 | 9.65 | 10.83 | 12.54 | 10.5 | 9.58 | 16.03 | 20.32 | 7.05 | 8.9 |
| Pre Tax Margin(%) | 4.27 | 4.19 | 3.85 | 6.05 | 7.5 | 6.23 | 4.84 | 13.73 | 19.01 | 5.41 | 7.18 |
| PAT Margin (%) | 3.19 | 3.28 | 2.13 | 4.14 | 5.58 | 4.62 | 2.95 | 8.82 | 15.57 | 3.95 | 5.28 |
| Cash Profit Margin (%) | 7.35 | 7.13 | 6.66 | 10.45 | 9.72 | 10.03 | 9.21 | 13.32 | 18.73 | 9.35 | 10.32 |
| ROA(%) | 3.47 | 3.38 | 2.14 | 4.62 | 7.12 | 4.03 | 2.17 | 8.71 | 21.19 | 3.39 | 4.86 |
| ROE(%) | 10.56 | 10.28 | 6.7 | 13.84 | 18.38 | 9.6 | 5.21 | 19.88 | 40.45 | 5.69 | 8.12 |
| ROCE(%) | 12.87 | 11.85 | 12.47 | 15.99 | 21.61 | 12.56 | 9.57 | 21.53 | 38.65 | 8.2 | 10.71 |
| Receivable days | 21.91 | 23.31 | 24.89 | 27.28 | 26.69 | 31.88 | 32.91 | 39.65 | 36.01 | 48.95 | 45.76 |
| Inventory Days | 21.97 | 22.34 | 24.04 | 19.66 | 20.16 | 38.09 | 44.01 | 26.95 | 19.53 | 31.32 | 27.86 |
| Payable days | 84.12 | 78.47 | 88.31 | 96.65 | 74.3 | 67.59 | 70.47 | 67.43 | 44.27 | 45.31 | 55.47 |
| PER(x) | 3.05 | 4.4 | 8.87 | 9.5 | 5.16 | 2.52 | 8.74 | 6.25 | 2.89 | 14.25 | 11 |
| Price/Book(x) | 0.31 | 0.43 | 0.56 | 1.25 | 0.86 | 0.23 | 0.43 | 1.13 | 1 | 0.79 | 0.86 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.23 | 1.05 |
| EV/Net Sales(x) | 0.51 | 0.66 | 0.66 | 0.73 | 0.58 | 0.43 | 0.62 | 0.79 | 0.52 | 0.73 | 0.72 |
| EV/Core EBITDA(x) | 3.5 | 4.59 | 4.19 | 4.15 | 2.82 | 2.71 | 3.94 | 3.87 | 2.19 | 7.39 | 5.13 |
| Net Sales Growth(%) | 0.99 | 5.12 | 14.09 | 27.61 | 1.35 | -13.64 | -3.03 | 51.21 | 52.47 | -33.53 | 13.14 |
| EBIT Growth(%) | 43.96 | 6.66 | 20.32 | 32.44 | 33.77 | -34.23 | -11.57 | 153.02 | 93.3 | -76.93 | 42.77 |
| PAT Growth(%) | 94.57 | 7.95 | -27.41 | 129.4 | 55.58 | -29.78 | -38.13 | 352.69 | 169.14 | -83.16 | 51.44 |
| EPS Growth(%) | 84.85 | 2.46 | -30.98 | 117.93 | 47.8 | -41.7 | -41.22 | 352.69 | 169.14 | -83.16 | 51.43 |
| Debt/Equity(x) | 1.1 | 1.31 | 1.38 | 1.15 | 0.7 | 0.74 | 0.78 | 0.59 | 0.21 | 0.27 | 0.28 |
| Current Ratio(x) | 0.59 | 0.66 | 0.64 | 0.74 | 1.01 | 1.02 | 1.03 | 1.13 | 1.35 | 1.1 | 1.14 |
| Quick Ratio(x) | 0.48 | 0.49 | 0.51 | 0.6 | 0.75 | 0.69 | 0.76 | 0.91 | 1.06 | 0.82 | 0.87 |
| Interest Cover(x) | 1.94 | 1.88 | 1.66 | 2.27 | 2.48 | 2.46 | 2.02 | 6.96 | 15.55 | 4.3 | 5.18 |
| Total Debt/Mcap(x) | 3.83 | 3.25 | 2.45 | 0.92 | 0.81 | 3.27 | 1.84 | 0.52 | 0.21 | 0.35 | 0.33 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.18 | 63.18 | 63.18 | 63.18 | 63.18 | 63.81 | 63.81 | 63.81 | 64.07 | 64.23 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.45 | 0.31 | 0.16 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 |
| Public | 36.8 | 36.8 | 36.8 | 36.8 | 36.8 | 36.18 | 36.18 | 35.72 | 35.6 | 35.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.77 | 6.77 | 6.77 | 6.77 | 6.77 | 6.83 | 6.83 | 6.83 | 6.86 | 6.88 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.03 | 0.02 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Public | 3.94 | 3.94 | 3.94 | 3.94 | 3.94 | 3.87 | 3.87 | 3.83 | 3.81 | 3.8 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
